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Abstract: Previous cognitive training games for stroke survivors required the close supervision
of therapists. We aim to demonstrate the preliminary therapeutic effectiveness of Neuro-World,
serious mobile games for cognitive training, in chronic stroke survivors with mild-to-moderate
cognitive impairment without therapist supervision. For that, we conducted a randomized,
controlled clinical trial at a single long-term care rehabilitation center with 50 stroke survivors
in the chronic stage with mild-to-moderate cognitive impairment. Participants were randomized to
standard medical care (n = 25) or standard medical care plus administration of Neuro-World (n = 25)
over 12 weeks. A two-way mixed model ANOVA and Tukey’s post hoc tests identified significant
differences in outcomes between the experimental and the control groups at post-intervention but
not at baseline. Within the experimental group, there were statistically significant improvements
in all the outcomes except for the language category of the Mini-Mental State Examination and
Digit Forward Span. The improvements were clinically significant for the total Mini-Mental State
Examination, Digit Forward Span, and Digit Backward Span. Within the control group, there were no
improvements in any of the outcomes. The practice of Neuro-World led to significant improvements
in cognitive function and marginal mitigation of depressive symptoms in chronic stroke survivors
with mild-to-moderate cognitive impairment.
Keywords: serious games; mobile games; cognitive impairment; cognitive rehabilitation; stroke
survivors; chronic stage
1. Introduction
Stroke is a leading cause of permanent disability, affecting nearly 800,000 individuals every year in
the United States alone [1]. Although motor impairments are a hallmark of stroke, cognitive impairments
are also prevalent in chronic-stage stroke survivors. These cognitive impairments are marked by, but not
limited to, diminished memory, attention, and executive function [2,3]. In addition to affecting patients’
activities of daily living and quality of life, prior studies have shown that cognitive impairments can
serve as a significant barrier to engagement in motor rehabilitation [4], thus affecting the recovery
of motor function [5,6]. Moreover, it has previously been reported that cognitive impairments are
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associated with a decrease in the long-term survival rate [2] and increased symptoms of depression [7],
which could lead to a deterioration of patients’ perceived well-being [8,9]. Therefore, stroke survivors
with cognitive impairments often experience difficulty achieving independent living [2], which results
in an increased rate of institutionalization [10] and cost of care [11]. The high financial burden of
stroke care often drives the clinical communities to actively consider discharging stroke survivors early
and engaging them with rehabilitation therapies in their residential settings [12]. However, patients
have thus far shown poor adherence to rehabilitation therapies when close supervision by therapists
is absent—for instance, in their home settings—thereby jeopardizing their continued recovery and
maintenance of their function [13]. Therefore, it is essential to devise effective and engaging therapeutic
interventions that can be self-administered by stroke survivors where access to therapists or in-person
therapy is limited (e.g., patients with mobility limitation or in rural/underserved areas).
Computer-based cognitive training tools have received tremendous interests in the clinical and
research communities to enable patients to self-administer therapy in their home and community
settings [14–16]. However, patients who self-administer computer-based remote training often
show poor adherence, and therapists’ frequent involvement was necessary to maintain patients’
engagement to the intervention [17]. As a potential means to enhance patients’ adherence to at-home
cognitive training, serious games have been considered to be a viable solution for a wide range of
populations, including healthy older adults [14,18], persons with mild cognitive impairments and/or
neurological conditions [19–21], and survivors of acquired brain injury such as stroke and traumatic
brain injury [15,16]. Serious games are video games designed for a primary purpose other than
entertainment and enjoyment, such as educating, informing, and enhancing patients’ health-related
conditions [22–24]. Serious games can complement conventional therapeutic programs to provide
additional training in remote settings [25,26]. The entertainment components of serious games
are an advantage to improve patients’ compliance to seemingly mundane, repetitive therapeutic
activities (e.g., non-game-assisted, computer-based cognitive training) [27], which are a major barrier
hindering patients’ potential functional recovery [28]. Furthermore, serious games could improve
patients’ engagement during therapeutic activities, which may lead to greater neuroplastic changes
and functional recovery in brain injury survivors [29].
Serious games for cognitive training in stroke survivors must be carefully designed to provide
simple and user-friendly interfaces so that stroke survivors with motor and cognitive impairments
can interact with the interfaces (e.g., a touchscreen or joystick) of the game systems without
caregivers’ close assistance outside the clinical setting [30]. However, existing game-assisted
cognitive training solutions do not provide adequate interfaces for individuals with some degree of
motor impairments. For example, CogMed and RehaCom—the two most widely studied cognitive
training game platforms—leverage a keyboard and a mouse [31–33] and a custom-designed
keyboard-like interface [34–37], respectively. These interfaces require bi-manual and/or fine-hand
motor skills [34–37], which could be especially challenging for stroke survivors who often have
hemiparesis and limited distal upper-limb motor function [38]. Furthermore, these games have been
primarily developed for their use in clinical settings, where therapists’ supervision is readily available.
For instance, individuals with acquired brain injury who used RehaCom had to rely on their therapists
to customize and administer game-based therapies [39].
Our research team has recently developed Neuro-World—a set of six serious games for
cognitive training on mobile devices (e.g., smartphones and tablet computers)—that provides simple
and user-friendly touchscreen interfaces so that stroke survivors, who often exhibit hemiparesis,
can self-operate the technology [40]. In the current work, we examine the therapeutic effectiveness of
our serious game-based training on improving cognitive function via a randomized controlled trial in
chronic-stage stroke survivors with mild-to-moderate cognitive and motor impairments. The study
was conducted in a clinical setting (i.e., nursing home associated with a rehabilitation hospital),
where participants were reminded of the training, although they were asked to self-operate the games
without any assistance from caregivers or research staff. Our underlying hypotheses included that
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(1) stroke survivors with hemiparesis could effectively self-operate Neuro-World and (2) chronic-stage
stroke survivors with mild-to-moderate cognitive impairment would significantly improve their
cognitive function after using Neuro-World for a 12-week period.
2. Materials and Methods
2.1. Neuro-World Games
We developed Neuro-World based on the findings that basic cognitive processes of memory
and attention underline various aspects of clinically important cognitive function [41], such as
orientation [42], registration, recall [43], and language [44]. These findings imply that training
on cognitive processes of memory and attention could lead to improvements in cognitive abilities.
Three games (Figure 1a–c) were designed based on concepts related to short-term memory, while the
other three (Figure 1d–f) were designed based on concepts related to selective attention. Each of
the six games had 20 different difficulty levels, where stage one was the easiest, and stage 20 was
the most difficult. The difficulty level of the six games was adjusted by changing game-specific
variables, such as the number of game items (e.g., animal avatars to memorize), the length and
pattern of the temporal sequence of the items, and the complexity of their visual characteristics
(see Table A1 for details). Each game started at stage one and proceeded to later stages as users
successfully completed the tasks. In each stage, users were given three chances to select the correct
answer. If users failed to provide the correct answer, the difficulty level was automatically reduced
by moving to the previous, easier stage. Each game has a predefined time limit of five minutes.
When the user uses up the predefined time limit for a game at any stage, the user will be automatically
proceeded to the next game (starting from the easiest stage). The detailed mechanics of each game is
explained in Appendix A. The user interface of Neuro-World was specifically designed to provide a
simple and user-friendly interface (e.g., large buttons to press on the touchscreen), such that stroke
survivors with hemiparesis could leverage only the unimanual, gross upper-limb movements to
operate the system. Furthermore, Neuro-World requires minimal configurations and automates most
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Figure 1. The screenshots of the six games of Neuro-World. All the games were administered in Korean,
and English translations were added post clinical study for readers. A detailed explanation for each
game is provided in Appendix A.
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2.2. Study Design and Enrollment
The experimental procedure was approved by the Institutional Review Boards (IRB) of the
University of Massachusetts Amherst (IRB# 2018-4728) and Heeyeon Rehabilitation Hospital, and the
approved clinical trial was registered (ISRCTN10613029). As it was the first clinical trial on Neuro-World
with post-stroke survivors, the sample size was computed conservatively, aiming for the minimum
effect size of f = 0.2, significance level of α = 0.05, and statistical power of β = 0.8. The computed
target sample size was 50. We recruited stroke survivors among those who had been institutionalized
in the Nursing Center at Heeyeon Rehabilitation Hospital in South Korea, a long-term care facility for
individuals with chronic disorders. Participant recruitment was open for one month until the targeted
number of patients was met. To be included in the study, participants had to be at least two years
post-stroke since most stroke survivors in South Korea have the opportunity to stay in rehabilitation
units for two years due to substantial subsidy by the public insurance. In addition, participants needed
to score 18 points or greater on the Korean version of the Mini-Mental State Examination (MMSE) [45].
Exclusion criteria were the presence of any issues that could affect the self-operation of Neuro-World,
such as physically being incapable of using a mobile device independently (i.e., both limbs do not
have the necessary motor function, indicated by the scores of 20 or less on the Manual Function
Test [46]) and vision-related issues (e.g., visual neglect). Eligible participants were randomized to the
control group (i.e., standard medical care) or the experimental group (i.e., standard medical care plus
Neuro-World) using a random number generator. Baseline tests were completed one week before the
first Neuro-World session and post-intervention tests were completed one week after the last session
for all the subjects by an experienced language pathologist (hereinafter referred to as assessor). The
assessor was only involved in the pre- and post-intervention assessments and blinded to the participant
group assignment.
Participants in the experimental group used Neuro-World for 30 min per day, twice a week
(i.e., Tuesdays and Thursdays), for 12 weeks. In each 30-min session, participants spent five minutes on
each of the six games. When the five minutes had elapsed for a given game (at any stage), users were
automatically directed to another randomly chosen Neuro-World game. When users reached the
highest stage (i.e., stage 20) of a given game within the five-minute duration, stage 20 was repeated
with randomized game-specific variables. On the days and times that participants agreed to play
Neuro-World, research staff visited the experimental group participants to bring a 12.2-inch tablet
computer (Galaxy Note Pro, Samsung) that was pre-installed with the Korean version of Neuro-World.
However, the research staff members did not provide any assistance when the participants were
using the system. Participants were allowed to freely choose where to play Neuro-World (e.g., on their
beds, couches, chairs in their room, or a lounge). The research staff collected the tablet computer
when participants finished the suggested 30 min of Neuro-World. Participants in both groups received
no additional cognitive or motor rehabilitation therapies other than standard medical care, which
included routine checkups (e.g., blood pressure tests, diabetes screening) and/or any medically
necessary treatments (e.g., decubitus ulcer).
2.3. Outcome Measures
2.3.1. Primary Outcome
The therapeutic effect of Neuro-World on the overall cognitive impairment level was measured
using the total score of the MMSE [45] due to its prevalent use in research and clinical communities [47].
The assessments were performed at baseline and again at post-intervention (i.e., after 12 weeks).
We believe that participants’ learning effects for the MMSE between the baseline and post-intervention
assessments were minimal, considering the study duration [48].
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2.3.2. Secondary Outcomes
The therapeutic effect of Neuro-World on various aspects of cognitive function was assessed using
the sub-scores of the MMSE (i.e., orientation, register, attention and calculation, recall, language).
In addition, attention and working memory were assessed using the Digit Forward Span (DFS) and
Digit Backward Span (DBS) of the Wechsler Adult Intelligence Scale-IV [49], respectively. The Geriatric
Depression Scale (GDS) was used to assess the severity of depressive symptoms [50], and the System
Usability Scale (SUS) was conducted to measure the perceived-usability of Neuro-World [51]. For all
the outcomes of cognitive capability and SUS, a positive net score indicated an improvement, whereas,
for GDS, a negative net score indicated an improvement. Among the outcomes, the results of the
SUS have been reported in our previous work [40], demonstrating overall “good” usability perceived
by the study participants [52]. All participants in this study were able to successfully self-operate
Neuro-World without any assistance from caregivers or therapists throughout the study period.
2.4. Statistical Analyses
Unpaired t-tests were used to compare the mean age, chronicity, and the MFT scores on both
the affected and unaffected limbs between the experimental and control groups. Chi-square tests
compared the ratio of females/males, left/right affected sides, and handedness between the groups.
A two-way mixed model ANOVA was used to identify the main effects and interactions between the
intervention (experimental vs. control) and time-course (baseline vs. post-intervention) of Neuro-World
on each outcome. Tukey’s post-hoc tests were used to assess statistical significance between and
within-group changes for each outcome. The threshold for significance was set to p < 0.05 a priori.
All analyses were performed using R software (version 3.5.3).
3. Results
3.1. Study Population
Figure 2 illustrates the participant onboarding procedure. Table 1 summarizes the participant
demographic information, further details of which are provided in Appendix C. All the participants
were recruited and screened for eligibility from 5 June 2018 through 12 June 2018, when the
targeted number of participants was met. At baseline, the experimental (EXP) and control (CON)
groups did not display statistically significant differences in the mean age (EXP: 72.71 ± 9.86
vs. CON: 72.67 ± 12.64 years, t(27) = 0.03, p = 0.98), the proportion of males and females (EXP:
0.14 vs. CON: 0.13, χ2(1) = 0.00, p = 1), the proportion of subjects with left and right hemiparesis
(EXP: 0.50 vs. CON: 0.36, χ2(1) = 0.15, p = 0.70), the mean MFT scores for both the affected
(EXP: 14 ± 9.65 vs. CON: 15.80 ± 6.60, t(27) = 0.59, p = 0.56) and the unaffected limbs (EXP:
27.07 ± 2.37 vs. CON: 28.33 ± 1.91, t(27) = 1.58, p = 0.13), and the proportion of left and right-handed
subjects (EXP: 0.07 vs. CON: 0.00, χ2(1) = 0.00, p = 0.97). However, the mean length of time
since the stroke (i.e., chronicity) of the experimental group was significantly greater than that of the
control group (EXP: 74.07 ± 40.84 vs. CON: 45.47 ± 19.82 months, t(27) = 2.43, p = 0.02) albeit both
being well within the chronic phase. None of the participants were diagnosed with any language
disorders (e.g., aphasia), which may introduce challenges in following text and audio instructions and
self-administering Neuro-world games.
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Table 1. Baseline patient demographic information.
Baseline Demographic Data for 29 Stroke Survivors Experimental Control
Patients, No. 14 15
Age, mean (standard deviation), y. 72.71 (9.86) 72.67 (12.64)
Sex, No. (%)
Men 2 (14.29) 2 (13.33)
Women 12 (85.71) 13 (86.67)
Diagnosis, No. (%)
Ischemic stroke 11 (78.57) 13 (86.67)
Hemorrhagic stroke 3 (21.43) 2 (13.33)
Chronicity, mean (standard deviation), m. 74.07 (40.84) 45.47 (19.82) *
Affected Side, No. (%)
Left 7 (50.00) 5 (35.71)
Right 7 (50.00) 9 (64.29)
Manual Function test, mean (standard deviation) score
Affected Limb 14.00 (9.65) 15.80 (6.60)
Unaffected Limb 27.07 (2.37) 28.33 (1.91)
MMSE, mean (standard deviation) score
Orientation 7.93 (1.82) 8.07 (1.49)
Register 2.57 (0.51) 2.13 (0.83)
Attention and calculation 2.57 (0.51) 2.13 (0.83)
Recall 1.21 (0.80) 0.67 (0.62)
Language 7.71 (0.83) 7.87 (0.63)
Total score 21.64 (1.08) 20.87 (1.30)
Digit spanning, mean (standard deviation) score
Forward 7.36 (2.17) 6.13 (1.25)
Backward 4.14 (1.29) 2.93 (0.88)
GDS, mean (standard deviation), score 3.79 (0.43) 4.00 (0.00)
* indicates that the difference is statistically significant (p < 0.05).
56 survivors were assessed for eligibility
6 did not meet inclusion criteria
50 underwent randomization
25 were assigned to Neuro-World plus
standard medical care
2 withdrew consent due to cognitive fatigue
4 withdrew consent due to health condition
5 discharged or transferred
14 completed the study and were included in analysis
25 were assigned to standard medical care
15 completed the study and were included in analysis
1 withdrew consent due to cognitive fatigue
4 withdrew consent due to health condition
5 discharged or transferred
Figure 2. Participant Onboarding Procedure. Fifty-six volunteered chronic stroke survivors were
screened for eligibility. Six were determined to be ineligible for the study because they scored less
than 18 points in the initial MMSE assessment. Fifty participants were randomly assigned to the
experimental vs. control groups. During the study, three participants expressed cognitive fatigue
during gameplay and withdrew their consent. Ten participants were either discharged or transferred
to other medical institutions. Eight participants withdrew their consents due to their health issues
(e.g., headache or pain from arthritis), which were not related to the administration of Neuro-World.
As a result, 14 participants from the experimental group and 15 participants from the control group
completed the study. All 14 participants from the experimental group who stayed in the study
completed the entire 24 sessions of Neuro-World gameplay (i.e., twice a week for 12 weeks).
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3.2. Outcomes
Figure 3 shows the means and standard deviations of the study outcomes for both the
experimental and control groups at baseline and post-intervention. The experimental group showed
statistically significant improvements in the overall cognitive level (MMSE), working memory (DBS),
and depressive symptoms (GDS) after adhering to the Neuro-World training for 12 weeks, while the
control group did not. No adverse effects were observed during the study period. More specifically,
a two-way mixed model ANOVA showed that there was a significant interaction between the effects
of intervention (experimental vs. control) and time (baseline vs. post-intervention) in the total
MMSE scores (p < 0.01). Tukey’s post-hoc tests further revealed that there was a statistically
significant increase in the mean MMSE scores between baseline (BASE) and post-intervention (POST)
in the experimental group (BASE: 21.64 ± 1.08 vs. POST: 27.57 ± 1.45, t.ratio(27) = 6.48, p < 0.01),
while there was a statistically significant decrease in the control group (BASE: 20.87 ± 1.30 vs.
POST: 16.40 ± 4.22, t.ratio(27) = −5.06, p < 0.01). We performed a comparative analysis between
the observed improvements in the total MMSE score vs. clinical information, including the brain
lesions, the types of stroke (ischemic vs. hemorrhagic), and chronicity, but did not find any
significant correlations. Furthermore, there was a statistically significant difference in the mean
MMSE between the experimental and the control groups at post-intervention (EXP: 27.57 ± 1.45 vs.
CON: 16.40 ± 4.22, t.ratio(27) = −12.43, p < 0.1) but with no differences at baseline (EXP: 21.64 ± 1.08






































































Figure 3. The means and the standard deviations of the total MMSE score and its category scores at
baseline and post-intervention (a–f). The means and the standard deviations of the DFS, DBS, and GDS
scores by groups at baseline and post-intervention (g–i).
4. Discussion
Towards our goal of supporting the independent administration of cognitive training in home and
community settings of stroke survivors, we developed a serious game solution, namely Neuro-World,
and evaluated its therapeutic effectiveness on cognitive function in chronic stroke survivors through
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a randomized controlled study. The results herein demonstrate that routine use of Neuro-World
(i.e., 30 min per day, twice a week) leads to improvements in several aspects of cognitive function,
as well as depressive symptoms, in chronic-stage stroke survivors. Specifically, we observed statistically
and clinically significant improvements in the total MMSE score [53] and the DBS [54]. We also observed
statistically significant improvements in the GDS and all the MMSE sub-categories other than language.
However, the improvement in the GDS was not clinically significant [55]. Furthermore, we observed
clinically significant improvements, although not statistically significant, in the DFS [54]. In the rest of
this section, we discuss in detail the results pertaining specifically to cognitive function (i.e., changes
in the total MMSE scores, DFS, and DBS). The discussions related to the results of the sub-categories of
MMSE and the GDS could be found in Appendixes D and E.
Previous randomized controlled studies that investigated the therapeutic effectiveness of cognitive
rehabilitation solutions suggest that Neuro-World has yielded comparable or greater improvements
in cognitive function. For instance, Zucchell et al. reported that acute-stage stroke survivors showed
a mean improvement of 2.6 points from 22.8 to 25.5 in the MMSE after 16 sessions of one-hour
conventional cognitive therapy (i.e., a total of up to 16 h per person) [56]. Prokopenko et al. also showed
a mean improvement of 3 points from 24 to 27 in the MMSE after 14 sessions (i.e., a total of up to 15 h
of training) of computer-based cognitive therapy [57]. Similarly, Kim et al. reported that 20 sessions
(i.e., a total of 10 h) of a combined program of virtual reality-based upper-limb motor rehabilitation
and computerized cognitive rehabilitation resulted in a mean improvement of 3.6 MMSE points from
17.4 to 21.0 in acute-phase stroke survivors [58]. Although promising, the improvements reported
in the above-mentioned studies—because they involved acute-stage stroke survivors—might have
been affected by spontaneous biological recovery during the initial months following the stroke [59].
Furthermore, the reported improvements in MMSE are not particularly greater than the minimal
clinically important changes (MCID) that are necessary to conclude clinical significance, which is from
2 to 4 points in MMSE [53]. On the other hand, our study involved stroke survivors who were in the
chronic stage with no spontaneous recovery, and the participants in the experimental group showed a
mean improvement of 5.93 MMSE points from 21.64 to 27.57 after 24 sessions (e.g., a total of 12 h) of
Neuro-World. Furthermore, the training dosage used in our study was smaller than previous studies
except for the study by Kim et al., which collectively emphasizes the clinical effectiveness and lower
burden of Neuro-World in cognitive training.
We also demonstrated the therapeutic effectiveness of Neuro-World in improving working memory
as assessed by the DBS. Previously, Ȧkerlund et al. reported that chronic-stage brain injury survivors
who completed 25 sessions of 30–45 min (e.g., a total of up to 19 h and 45 min) of CogMed—a set of
serious games that are specifically designed to train working memory—showed an average increase
of 0.61 points in the DBS [60], although the improvement was not greater than the MCID of the DBS
(i.e., 1 point) [54]. Westerberg et al. showed a mean improvement of 1.5 points from 5.8 to 7.3 in
the MMSE after 25 sessions (e.g., a total of over 16 h) of CogMed [31], which is comparable to the
results reported herein: an average increase of 1.79 points in the DBS from 4.14 to 5.93 after 12 h of
Neuro-World play. It is noteworthy that CogMed includes a game that specifically targets the DBS by
displaying a sequence of numbers and instructing users to remember and reproduce the sequence in
reverse order [31]. On the other hand, Neuro-World includes games that ask users to remember and
reproduce a sequence of animals, leaving a farm to train working memory, which does not replicate
the DBS. There exist studies that reported statistically significant improvements in the DFS after
conventional or game-based interventions [56,60]. However, in our study, stroke survivors showed
only non-statistically significant improvement in the DFS. This is likely because the participants in our
study scored 7.36 on average at baseline, a relatively high score for the DFS [61], which yields limited
room for improvement (i.e., ceiling effect).
We envision a clinical scenario in which stroke survivors will first be introduced to Neuro-World
while they receive treatments in inpatient facilities. Then, stroke survivors could be prescribed to
use Neuro-World in outpatient facilities, in addition to the routine motor and cognitive rehabilitation
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programs, to enable frequent, low-cost, high-dosage cognitive rehabilitation in naturalistic settings.
Stroke survivors’ compliance level to Neuro-World (e.g., frequency and duration of gameplays) can be
summarized and made available to clinicians, such that clinicians can remotely follow up (e.g., a phone
call or SMS) to improve patients’ adherence to the intervention regimen. Although this remote
management of stroke survivors may impose additional burden for clinicians, we believe mobile
rehabilitation systems, in turn, will decrease the overall healthcare cost for chronic stroke survivors
in the long-term [62]. We may also consider leveraging patient-centered mobile-health solutions
(e.g., smartwatch or smartphone-based reminder systems) that use data-driven, personalized health
information as part of reminders to promote positive health-related behaviors (e.g., adhering to
at-home training) [63,64]. For example, our prior study has shown that quantitative measurements
of stroke survivors’ game performance in Neuro-World (e.g., average duration to complete a stage,
the most difficult stages reached for each game, etc.) can be analyzed via machine learning algorithms
to accurately estimate their cognitive level in terms of MMSE [40]. In other words, Neuro-World could
not only be used as a training tool but also as an assessment tool for cognitive level, such that patients
can self-monitor the recovery process. Furthermore, clinicians could also use the information to closely
monitor patients’ longitudinal recovery trajectories and devise individually tailored therapy programs
to maximize the chances of independent living, which is the ultimate goal of rehabilitation.
The current study has several limitations. First, the study had a relatively small sample size.
However, the preliminary results reported herein warrant a larger scale study, which would examine
the effect of Neuro-World with respect to the level of patients’ education, different domains of cognitive
function, stroke subtypes (e.g., size and location), or other medical factors. Second, the passive
control group showed unexpected decreases in all outcome measures, where the decrease in the
total MMSE score was statistically and clinically significant. At the completion of the data analysis,
we subsequently followed up with the assessor to understand the potential factors that could have
resulted in this unexpected decrease. After reviewing the data, the assessor suggested that most subjects
(i.e., 13 out of 15 subjects) in the control group were less cooperative and poorly engaged during
the post-intervention assessment, which may have led to the decrease in the scores rather than from
actual deterioration of their cognitive function. We believe this is due partially to the fact that control
subjects did not receive any interventions, follow-ups, or therapeutic/monetary compensations. Third,
there exists a statistically significant difference in the mean chronicity between the experiment and
control groups, which may have influenced the observed changes in the study participants’ cognitive
function. However, all participants were more than 12 months beyond their stroke which, by definition,
puts them in the chronic stage with minimal spontaneous recovery. Furthermore, the chronicity
of participants in the experiment group (75.04 ± 40.84 months) was significantly greater than the
control group (45.47 ± 19.82 months) which greatly diminishes the possibility of any spontaneous
recovery. Hence, we believe it is unlikely that this statistically significant cognitive improvement in
the experimental group could stem from spontaneous recovery. Fourth, the rehabilitation dosage (i.e.,
30 min of gameplay, twice a week, for 12 weeks) was chosen arbitrarily by referring to the dosages
used in prior studies involving serious games. Although our results suggest that chronic-stage stroke
survivors can improve their cognitive function when prescribed with this particular dosage, it remains
as an important future study to investigate the optimal dosage of the Neuro-World therapy. Prior studies
have shown that older adults with cognitive impairments are amenable to receiving game-based
training up to four times a week [18,20,65]. Thus, we may explore the impact of higher intervention
dosage on the clinical outcomes. Last, the goal of this study was to evaluate the effectiveness
of Neuro-World in improving cognitive level assuming perfect adherence. Hence, other than the
entertainment components of the Neuro-World games, we did not employ the components that support
other motivating factors, such as self-monitoring of functional improvements [66,67] and providing
feedback that is personalized to a specific patient’s condition [68,69]. It remains an important future
study to investigate and develop a patient-centered, interactive system that could support motivational
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factors to further improve patients’ adherence and engagement when they self-administer Neuro-World
in uncontrolled settings.
5. Conclusions
The current randomized controlled trial demonstrates that Neuro-World, a mobile serious game
platform that was developed for remote cognitive training, could be an effective means to improve
cognitive abilities in chronic-stage stroke survivors with mild-to-moderate cognitive impairment.
The preliminary results presented herein warrant a large-scale study to investigate the ultimate
goal of enabling stroke survivors’ self-administration of the game-assisted cognitive training in their
home settings.
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Appendix A. Neuro-World Games
The first three games (Figure 1a–c) were designed to stimulate memory using visual information,
the concept of which is related to short-term memory. In the first game (Figure 1a), when the game is
started, a flock of animal avatars enters the farm simultaneously, and a subset of the flock leaves in one
of the four directions (i.e., up, down, left, right). Then, the game presents the image of one animal at
the bottom center of the screen and instructs the user to select the direction that the animal has left the
farm. The user can select an answer by touching one of the four arrows (i.e., directions) on the screen.
As the user proceeds to higher stages, the number and the moving speed of animals entering and
exiting the farm increase (more detailed mechanics of difficulty level adjustment for all the Neuro-World
games is provided in Table A1). In the second game (Figure 1b), a flock of animals enters the farm
simultaneously, and a subset of the flock leaves the farm as in the first game. The images of animals
are presented at the bottom center of the screen. The user is expected to remember the animals that
have left the farm and provide an answer by touching the corresponding animal images on the screen.
In higher stages, the number of animals that enter and exit the farm increase. In the third game
(Figure 1c), a flock of animals enters the farm one after another in a specific order, and a subset of the
flock leaves the farm simultaneously. The user is expected to remember the order that the remaining
animals have entered the farm and select them in the correct order by touching them on the screen.
In higher stages, the total number of animals, the number of remaining animals, and their moving
speed increase.
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Table A1. The mechanics of how difficulty levels are adjusted for Neuro-World games.
Game Mechanics of Difficulty Adjustment
1 One animal enters and leaves the farm in stage one whereas, in stage 20, ten animals enter and five
of them leave. The speed of all the animals in stage 20 move 2.1 times faster than the speed in stage
one when entering and leaving the farm.
2 One animal enters and leaves the farm in stage one whereas, in stage 20, ten animals enter and four
of them leave the farm.
3 Three animals enter and all three animals remain on the farm in stage one. In stage 20, 16 animals
enter and 12 of them remain on the farm. The speed of all the animals in stage 20 move 3.2 times
faster than the speed in stage one when entering and leaving the farm.
4 A total of four animals are presented while 40 animals are presented in stage 20. In stage one, each
type of animal has only one color whereas, in stage 20, each type of animal has multiple skin colors.
5 Two animals are presented in stage one whereas nine animals are presented in stage 20.
6 Only one shape is used to make a sequence in stage one whereas 15 different combinations of
primitive shapes are used in stage 20. The sequence presented at the bottom of the screen consists
of seven (identical) shapes in stage one and 14 shapes (using different combinations of primitive
shapes) in stage 20.
The next three games (Figure 1d–f) were designed based on concepts related to selective attention.
In the fourth game ((Figure 1d), a flock of animals with different visual characteristics is displayed on
the screen, in which a subset of the flock shares some common features, such as the type (e.g., dog vs.
sheep) and color. A recorded verbal instruction (e.g., ‘Count the number of brown chickens!’) is played
to describe the common visual features of the animals that the user needs to count. Users can replay
the recorded instructions by touching a button at the top left corner of the screen (i.e., ‘Repeat Speech
Instruction’). When the user finishes the counting, he/she can touch the button (i.e., ‘Enter Answer’),
which will provide a visual interface that allows the user to input the numbers. In higher stages,
the total number of animals increases, and the features of the presented animals become more diverse.
In the fifth game (Figure 1e), a flock of animals is presented on the screen. The image of the animal
that the user needs to find among the flock is visually presented at the bottom center of the screen.
The game instructs the user to identify the matching animal among the presented animals. In higher
stages, the difficulty level is increased by presenting a larger number of animals with more complex
visual features. In the sixth game (Figure 1f), a sequence of complex shapes (items), each of which
combines multiple primitive 3D shapes and colors, is sequentially looped on the screen. For instance,
a sequence of an orange-colored hexagonal pyramid on top of a circular support followed by a yellow
cylinder on a triangular support and then by an orange cylinder on a circular support is repeated on
the screen. The game ends the sequence at a randomly selected item and instructs the user to identify
the color and shapes of the item that should follow the sequence. In higher stages, the type of primitive
shapes and the sequential pattern become more complex.
Appendix B. Neuro-World Games
Table A2 provides a detailed analysis of participants’ gameplay data for each of the six Neuro-World
games. The analysis suggests that the participants found game one (Figure 1a) and four (Figure 1d)
particularly easy to play. Participants were able to reach stage 20 for both games and the correct answer
rate was 70% and 68% respectively. The participants found game three (Figure 1c) particularly difficult
to play as indicated by every aspect of the analysis data. The participants were able to reach stage six
on average. During the five minutes given to the participants, on average, they were able to attempt
only four different gameplays and spent about 100 s for each. The rate of correct answers was also the
lowest among all six games.
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Table A2. Analysis of participants’ gameplay data.
Gameplay Data Game 1 Game 2 Game 3 Game 4 Game 5 Game 6
Highest mean (std) stage 20 (0) 18 (3) 6 (2) 20 (0) 13 (3) 20 (1)
Gameplay mean (std) count 18 (4) 9 (1) 4 (1) 11 (2) 47 (14) 5 (1)
Time for each gameplay, mean (std) seconds 17 (4) 37 (3) 100 (46) 30 (7) 7 (2) 50 (67)
Rate of correct answer, mean (std) % 70 (19) 45 (16) 42 (19) 68 (18) 60 (21) 60 (19)
Appendix C. Study Population
Tables A3 and A4 describe the demographic characteristics of the participants in the experimental
and the control groups, respectively. The information about brain legion for some participants was
missing in their medical records, which is marked as N/A in the tables.
Table A3. Patient demographic information for the experimental group.
ID Age Sex Diagnosis Chronicity Affected Side MFT (Lt/Rt) Location of Stroke Handedness
1 66 F Isc 156 Lt 5/23 N/A Rt
2 81 F Isc 121 Rt 27/22 N/A Rt
3 62 F Isc 108 Lt 2/28 MCA Inf Rt
4 71 F Isc & Alz 78 Lt 0/28 N/A Rt
5 85 F Isc 38 Lt 22/27 N/A Rt
6 72 F Isc 54 Rt 29/25 N/A Rt
7 80 M Hem 64 Lt 23/24 T SDH Rt
8 75 F Isc 76 Rt 29/22 N/A Rt
9 77 F Isc 41 Rt 28/10 Lt MCA Inf Lt
10 64 F Hem 132 Lt 7/31 N/A Rt
11 85 F Isc 24 Rt 26/21 N/A Rt
12 50 M Hem 72 Rt 29/10 Lt FPT SDH Rt
13 70 F Isc 35 Rt 23/2 Rt BG, IC Inf Rt
14 80 F Isc 38 Lt 25/27 Lt BG Inf Rt
Age is in years and chronicity is in months; MFT: Manual Function Test, F: Female, M: Male, Isc: Ischemic,
Hem: Hemorrhagic, Alz: Alzheimer, Lt: Left, Rt: Right, Inf: Infarction, BG: Basal Ganglia, IC: Internal Capsule,
MCA: Middle Cerebral Artery, SDH: SubDural Hemorrhage, F: Frontal lobe, P: Parietal lobe, T: Temporal lobe.
Table A4. Patient demographic information for the control group.
ID Age Sex Diagnosis Chronicity Affected Side MFT (Lt/Rt) Location of Stroke Handedness
1 81 F Isc 58 Lt 22/26 Rt ACA Inf Rt
2 87 F Isc 36 Lt 9/25 Rt MCA Inf Rt
3 76 F Isc 53 Rt 29/11 N/A Rt
4 87 F Isc 70 Lt 19/25 N/A Rt
5 77 F Isc 40 Rt 29/4 BG Inf w/ HT Rt
6 87 F Isc 64 Rt 28/17 N/A Rt
7 49 F Isc 24 Rt 30/13 Lt TH Rt
8 66 F Hem 68 Rt 31/26 N/A Rt
9 56 F Isc 48 Lt 8/29 N/A Rt
10 80 F Isc 37 Rt 29/24 MCA, PCA Inf Rt
11 78 F Isc 84 GD 30/31 BL PVWM Inf Rt
12 73 F Isc 28 Rt 30/23 Lt TH Inf Rt
13 67 M Isc 24 Rt 28/12 N/A Rt
14 75 F Hem 24 Lt 18/27 O ICH Rt
15 50 M Isc 24 Rt 28/11 Rt BG Inf Rt
Age is in years and chronicity is in months; MFT: Manual Function Test, F: Female, M: Male, Isc: Ischemic,
Hem: Hemorrhagic, Lt: Left, Rt: Right, GD: Gait Disturbance, BL: Bilateral, ACA: Anterior Cerebral Artery,
MCA: Middle Cerebral Artery, PCA: Posterior Cerebral Artery, PVWM: PeriVentricular White Matter, Inf:
Infarction, HT: Hemorrhagic Transformation, TH: Thalamic Hemorrhage, O: Occipital lobe.
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Appendix D. Secondary Cognitive Outcomes
Table A5. The results of a two-way mixed model ANOVA for intervention (i.e., between-subjects effect)








F(1, 27) p F(1, 27) p F(1, 27) p
Total MMSE 88.33 < 0.001 0.75 0.39 66.87 < 0.001
Orientation 4.86 0.04 0.03 0.85 15.42 < 0.001
Register 23.10 < 0.001 3.66 0.07 41.49 < 0.001
Attention & Calculation 18.36 < 0.001 5.44 0.03 20.15 < 0.001
Recall 69.68 < 0.001 27.57 < 0.001 67.25 < 0.001
Language 8.23 0.008 3.22 0.08 12.45 0.002
DFS 16.71 < 0.001 0.18 0.67 9.16 0.005
DBS 33.81 < 0.001 1.22 0.28 19.87 < 0.001
GDS 46.16 < 0.001 4.91 0.04 23.31 < 0.001
Table A6. Tuckey’s post hoc test results between baseline and post-intervention tests in the experimental






t.ratio(27) p t.ratio(27) p
Total MMSE 6.48 < 0.001 −5.06 < 0.001
Orientation 2.96 0.03 −2.60 0.07
Register 3.30 0.01 −5.85 < 0.001
Attention & Calculation 4.85 < 0.001 −1.44 0.49
Recall 9.55 < 0.001 −1.92 0.24
Language 1.29 0.58 −3.74 0.005
DFS 2.48 0.09 −1.79 0.30
DBS 3.97 0.003 −2.30 0.12
GDS −5.01 < 0.001 1.76 0.31







t.ratio(27) p t.ratio(27) p
Total MMSE −0.86 0.82 −12.43 < 0.001
Orientation 0.20 > 0.99 −3.95 0.003
Register −1.90 0.25 −6.94 < 0.001
Attention & Calculation −1.02 0.74 −6.07 < 0.001
Recall −2.42 0.10 −11.49 < 0.001
Language 0.47 0.97 −4.52 < 0.001
DFS −1.50 0.45 −5.09 < 0.001
DBS −2.22 0.14 −7.32 < 0.001
GDS 1.39 0.52 8.22 < 0.001
Further analyses on the sub-scores of the MMSE and the DFS support the therapeutic benefits of a
serious game-based cognitive training method (i.e., Neuro-World) for improving the cognitive function
and attention in chronic-stage stroke survivors over no therapy. From the two-way mixed model
ANOVA, statistically significant interactions for intervention and time in all the assessed outcomes,
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including the MMSE sub-scores and the DFS scores, were observed (Table A5). The Tukey’s post-hoc
test showed that among the MMSE categories, the experimental group achieved statistically significant
increases in the orientation (BASE: 7.93 ± 1.82 vs. POST: 8.07 ± 1.49, t.ratio(27) = 2.96, p < 0.05),
register (BASE: 2.57 ± 0.51 vs. POST: 3.00 ± 0.00, t.ratio(27) = 3.30, p < 0.05), attention & calculation
(BASE: 2.57 ± 0.51 vs. POST: 3.00 ± 0.00, t.ratio(27) = 4.85, p < 0.01), and recall (BASE: 1.21 ± 0.80
vs. POST: 2.93 ± 0.27, t.ratio(27) = 9.55, p < 0.01) categories and non-statistically significant increase
in the language (BASE: 7.71 ± 0.83 vs. POST: 8.14 ± 0.53, t.ratio(27) = 1.29, p = 0.58) category
(Tables A6 and A7). On the other hand, the control group exhibited non-statistically significant
decreases in the orientation (BASE: 8.07 ± 1.49 vs. POST: 6.73 ± 2.79, t.ratio(27) = −2.60, p = 0.07),
the attention & calculation (BASE: 2.13 ± 0.83 vs. POST: 1.40 ± 0.74, t.ratio(27) = −1.44, p = 0.49),
the recall (BASE: 0.67 ± 0.62 vs. POST: 0.33 ± 0.62, t.ratio(27) = −1.92, p = 0.24) categories
and statistically significant decreases in the register (BASE: 2.13 ± 0.83 vs. POST: 1.40 ± 0.74,
t.ratio(27) = −5.85, p =< 0.01) and the language (BASE: 7.87 ± 0.64 vs. POST: 6.7 ± 1.29,
t.ratio(27) = −3.74, p = 0.01) categories. This trend of improvements in cognitive function is further
supported by the analysis results of the DFS. The experimental group exhibited non-statistically
significant increase in the DFS (BASE: 7.36 ± 2.17 vs. POST: 9.07 ± 2.87, t.ratio(27) = 2.48, p = 0.09),
while the control group showed marginal decrease in the DFS (BASE: 6.13 ± 1.25 vs. POST: 4.93 ± 2.22,
t.ratio(27) = −1.79, p = 0.30). Despite the non-statistical significance, these changes are still clinically
meaningful, considering the minimal clinically important changes of the DFS (i.e., 1 DFS point) [54].
Tukey’s post-hoc tests further revealed that while the experimental and the control groups showed
no statistical difference in all the MMSE categories and the DFS at baseline, there was a trend toward
greater improvements for the experimental group when compared to the control group. These results
collectively suggest that Neuro-World training for a three-month period can improve the overall
cognitive level and attention in chronic-stage stroke survivors.
Appendix E. GDS Results and Implications
Another factor that can lead to long-term disability in stroke survivors is post-stroke depression,
which is reported in 5 to 64% [70,71] of stroke survivors. Post-stroke depression is associated with
increased mortality risk, impairments in motor function, and deterioration in the quality of life [72,73].
After the three-month intervention, the experimental group showed a statistically significant decrease
in the symptoms of depression, while the control group showed a non-statistically significant increase.
Although all the study participants in both the experimental and control groups showed clinically
insignificant depressive symptoms (GDS ≤ 4) at baseline, Neuro-World gameplay appears to have
ameliorated depressive symptoms in the experimental group, which was statistically significant
(BASE: 3.79 ± 0.43 vs. POST: 3.00 ± 0.55, t.ratio(27) = −5.01, p < 0.01). On the other hand, although
statistically not significant, the control group showed a deterioration in their depressive symptoms
between baseline and post-intervention (BASE: 4.00 ± 0.00 vs. POST: 4.27 ± 0.46, t.ratio(27) = 1.27,
p = 0.31). More importantly, four study participants in the control group became marginally depressed
at the post-intervention visit (GDS ≥ 5).
However, despite the statistically significant improvement in the GDS score in the experimental
group participants, the baseline GDS scores represented non-depressive symptoms (i.e., normal
condition), and the observed change (−0.79 ± 0.70) was smaller than the minimal clinically important
changes (i.e., 5.4 GDS point) [55]. Hence, although our results show that Neuro-World has the potential
to reduce or control depressive symptoms, future work should focus on using Neuro-World in chronic
stroke survivors exhibiting more depressive symptoms (GDS ≥ 5) to more rigorously examine whether
the use of Neuro-World can lead to clinically significant changes in depressive symptoms.
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